Last, IL-18 has been identified to correlate positively with the severity of PBC in patients,31 was tendentially increased in patients with PSC32 and has been shown to increase the risk of liver injury in a non-alcoholic fatty liver disease mouse model.33 Here, IL18 is linked to primary biliary cholangitis.